IPSC Century Therapeutics, Inc.
$1.94▲ +0.00%
Healthcare
Other
After hours
$1.94▲ +0.00%
Sep 11, 7:30 PM ET
Volume 465.7K
Avg Volume (10D) 399.6K
Key Metrics & Fundamentals
Market Cap
$351.29M
P/E Ratio
–
Div Yield
–%
52W Range
0.44 - 3.04
% vs 50 MA
-7.83%
% vs 200 MA
-1.94%
RSI-14
41.7
MACD Histogram
-0.0100
Beta (1Y vs SPY)
2.10
Free Cash Flow
-$20.53M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$11.62M
COGS
–
Operating Exp
$25.38M
Operating Income
-$25.38M
EBIT
-$25.38M
Pretax Income
-$34.55M
Net Income
-$34.55M
EPS (Diluted)
-0.17
Price & Volume History
Loading chart…
Recent News
Century Therapeutics Appoints Joseph Truitt to Board of Directors
GlobeNewswire · Sep 9, 2026 8:05 PM
Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
GlobeNewswire · Aug 12, 2026 12:00 PM
Century Therapeutics (IPSC) to Present CNTY-813 Data at Scientific Congresses
Insider Monkey · Jul 14, 2026 10:33 AM
Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026
GlobeNewswire · Jul 9, 2026 12:00 PM
Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing Healthcare Investments | DelveInsight
GlobeNewswire · Jun 22, 2026 5:00 PM
Financial Overview - Income Statement
Quarterly
Mar 2025
See IPSC's money flow as a full page
Social Sentiment
No Reddit posts found for IPSC.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.